CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop FRANKFURT, Germany (AP) Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by mutual agreement with the companys board of directors, citing recent market challenges and a steep decline in the companys share price
Much could change between now and January 1, 2028, when Bridge sunsets
Side effects track dose increases, not the absolute dose, and they improve on a stable dose
During your consult, youll discuss your goals, dosing options, and what to expect
Saavedra-Bonilla H, Varman DR, ReyesHaro D (2024) Spontaneous calcium transients recorded from striatal astrocytes in a preclinical model of autism
I love being able to have help staying healthy and managing my weight